Katinka Kansy1, Oliver Thiele, Kolja Freier. 1. Department of Oral and Maxillofacial Surgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany, katinka.kansy@med.uni-heidelberg.de.
Abstract
INTRODUCTION: As the traditional risk factors for oral squamous cell carcinoma, especially tobacco, decline, new potential causative agents become the focus of research. Since the discovery of human papillomavirus (HPV) and its importance in carcinogenesis in cervical cancer, a lot of research has been undertaken to define its role in different types of cancer. In the present study, we evaluate the role of high-risk HPV types in initiation and progression of oral squamous cell carcinoma (OSCC) using a systematic review of the current literature. MATERIAL AND METHODS: A literature research with the search term "HPV oral squamous cell carcinoma" was performed via PubMed. Results were screened systematically for relevance and classified into the following categories: molecular biology, genetics, clinical aspects, and prevalence. Articles were then further analyzed to assess quality. RESULTS: The literature research led to 527 results, with an overall HPV prevalence of 30.1 % in OSCCs. The most frequently identified subtypes were HPV-16 and HPV-18 (25.4 and 18.1 %, respectively). Prognostic relevance of HPV was discussed controversially. HPV detection via polymerase chain reaction is the most established method today. Molecular changes according to carcinogenic pathways described for cervix carcinoma were not routinely found in OSCC. In general, no definite role of high-risk HPV is currently deducible from the literature. CONCLUSIONS: High-risk subtypes 16 and 18 are present in the genome in approximately one third of OSCC. Its role as a causative agent is less clear than the role in oropharyngeal tumors. The infection might not be the cause of carcinogenesis in a significant number of patients but may become proportionally more important with the decrease of the classical risk factors of tobacco and alcohol.
INTRODUCTION: As the traditional risk factors for oral squamous cell carcinoma, especially tobacco, decline, new potential causative agents become the focus of research. Since the discovery of human papillomavirus (HPV) and its importance in carcinogenesis in cervical cancer, a lot of research has been undertaken to define its role in different types of cancer. In the present study, we evaluate the role of high-risk HPV types in initiation and progression of oral squamous cell carcinoma (OSCC) using a systematic review of the current literature. MATERIAL AND METHODS: A literature research with the search term "HPV oral squamous cell carcinoma" was performed via PubMed. Results were screened systematically for relevance and classified into the following categories: molecular biology, genetics, clinical aspects, and prevalence. Articles were then further analyzed to assess quality. RESULTS: The literature research led to 527 results, with an overall HPV prevalence of 30.1 % in OSCCs. The most frequently identified subtypes were HPV-16 and HPV-18 (25.4 and 18.1 %, respectively). Prognostic relevance of HPV was discussed controversially. HPV detection via polymerase chain reaction is the most established method today. Molecular changes according to carcinogenic pathways described for cervix carcinoma were not routinely found in OSCC. In general, no definite role of high-risk HPV is currently deducible from the literature. CONCLUSIONS: High-risk subtypes 16 and 18 are present in the genome in approximately one third of OSCC. Its role as a causative agent is less clear than the role in oropharyngeal tumors. The infection might not be the cause of carcinogenesis in a significant number of patients but may become proportionally more important with the decrease of the classical risk factors of tobacco and alcohol.
Authors: G Campisi; L Giovannelli; F Calvino; D Matranga; G Colella; C Di Liberto; G Capra; J C Leao; L Lo Muzio; M Capogreco; M D'Angelo Journal: Oral Oncol Date: 2006-02-17 Impact factor: 5.337
Authors: J Laco; J Nekvindova; V Novakova; P Celakovsky; H Dolezalova; L Tucek; H Vosmikova; M Vosmik; T Neskudlova; E Cermakova; M Hacova; F A Sobande; A Ryska Journal: Neoplasma Date: 2012 Impact factor: 2.575
Authors: Simon F Preuss; Andreas Anagiotos; Inga M C Seuthe; Uta Drebber; Inga Wedemeyer; Matthias Kreppel; Robert Semrau; Guy D Eslick; Jens Peter Klussmann; Christian U Huebbers Journal: Eur Arch Otorhinolaryngol Date: 2014-06-01 Impact factor: 2.503
Authors: Yasmin Ghantous; Mohamed Omar; Esther Channah Broner; Nishant Agrawal; Alexander T Pearson; Ari J Rosenberg; Vasudha Mishra; Alka Singh; Imad Abu El-Naaj; Peter A Savage; David Sidransky; Luigi Marchionni; Evgeny Izumchenko Journal: Int J Cancer Date: 2021-10-14 Impact factor: 7.396
Authors: Jeroen K Buskermolen; Christianne M A Reijnders; Sander W Spiekstra; Thorsten Steinberg; Cornelis J Kleverlaan; Albert J Feilzer; Astrid D Bakker; Susan Gibbs Journal: Tissue Eng Part C Methods Date: 2016-08 Impact factor: 3.056
Authors: Felipe Maurício Soeiro Sampaio; Marcela Duarte Benez Miller; Gustavo Vieira Gualberto; Maria Clara Gutierrez Galhardo; Antonio Carlos Francesconi do Valle; Paulo Roberto Cotrim de Souza Journal: An Bras Dermatol Date: 2013 Nov-Dec Impact factor: 1.896